Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
The Prostate
|
April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
Catherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
The Prostate
|
April 8, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics
Sheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
Clinical Genitourinary Cancer
|
September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Mark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
European Urology
|
October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects
Pedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.
Tomography (Ann Arbor, Mich.)
|
March 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on <sup>18</sup>F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort
Md Zobaer Islam, Timothy G Perk, Amy Weisman, et al.
European Urology
|
June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer
Pedro Isaacsson Velho, Wei Fu, Hao Wang, et al.
Molecular Cancer Research : MCR
|
May 1, 2026
HLA Class I Expression is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Adrianna Amaral, Thiago Vidotto, Juhyung Woo, et al.
JCO Precision Oncology
|
October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy
Pedro Isaacsson Velho, David Lim, Hao Wang, et al.
The Oncologist
|
April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
The Prostate
|
April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
Catherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
The Prostate
|
April 8, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics
Sheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
Clinical Genitourinary Cancer
|
September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Mark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
European Urology
|
October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects
Pedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.
Tomography (Ann Arbor, Mich.)
|
March 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on <sup>18</sup>F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort
Md Zobaer Islam, Timothy G Perk, Amy Weisman, et al.
European Urology
|
June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer
Pedro Isaacsson Velho, Wei Fu, Hao Wang, et al.
Molecular Cancer Research : MCR
|
May 1, 2026
HLA Class I Expression is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer
Adrianna Amaral, Thiago Vidotto, Juhyung Woo, et al.
JCO Precision Oncology
|
October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy
Pedro Isaacsson Velho, David Lim, Hao Wang, et al.
The Oncologist
|
April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.
Page
of 8